Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
I will be working across government to ensure that we work to stop HIV transmissions for good ... and allows people to access ...
The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...
Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...
Failure to ensure that everyone has access to prevention options to protect oneself from HIV acquisition, has resulted in at ...
The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.